¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"tissue maximum ratio"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • respiratory exchange ratio
    È£Èí±³È¯ºñÀ²
  • risk benefit ratio
    À§ÇèÆíÀͺñ
  • risk ratio
    À§Çèºñ
  • standardized mortality ratio
    Ç¥ÁØÈ­»ç¸Áºñ
  • standardized rate ratio
    Ç¥ÁØÈ­ºñÀ²ºñ
  • stopping power ratio
    ÀúÁö´Éºñ
  • survival ratio
    »ýÁ¸ºñ
  • segregation ratio
    ºÐ¸®ºñ
  • serum urea nitrogen/creatinine ratio
    Ç÷û¿ä¼ÒÁú¼Ò/Å©·¹¾ÆÆ¼´Ñºñ
  • sex ratio
    ¼ººñ
  • signal-to-noise ratio
    ½ÅÈ£´ëÀâÀ½ºñ
  • uptake ratio
    ¼·ÃëÀ²
  • urea excretion ratio
    ¿ä¼Ò¹è¼³ºñ
  • velocity ratio
    ¼Óµµºñ
  • ventilation blood flow ratio
    ȯ±âÇ÷·ùºñÀ²
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • depth to width ratio
    ±íÀÌÆøºñÀ²
  • dextrose-nitrogen ratio
    Æ÷µµ´çÁú¼Òºñ
  • dilution ratio
    ¹±Èûºñ, Èñ¼®ºñ
  • disease odds ratio
    Áúº´±³Â÷ºñ
  • distribution ratio
    ºÐÆ÷ºñÀ²
  • exposure ratio
    ³ëÃâºñÀ²
  • exposure-odds ratio
    ³ëÃâ±³Â÷ºñ
  • extraction ratio
    ÃßÃâ·ü
  • ratio estimate
    ºñÀ²ÃßÁ¤°ª
  • fetal death ratio
    žƻç¸Áºñ
  • gas exchange ratio
    °¡½º±³È¯ºñÀ²
  • gyromagnetic ratio
    ȸÀüÀÚ±âºñÀ²
  • heart lung ratio
    ½ÉÆó°è¼ö, ½ÉÀåÈä°ûºñ
  • hydrodynamic ratio
    ¼ö·ÂÇкñÀ²
  • innervation ratio
    ½Å°æÁö¹èºñ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • optimal proportion =o. ratio
    ÃÖÀûºñ (Ì§ËøËÓ).
  • optimal ratio
    ÃÖÀûºñ.
  • optimum ratio
    ÃÖÀûºñ
  • optimum ratio
    ÃÖÀûºñ(õÌîêÝï).
  • oxygen enhancement ratio (OER)
    »ê¼ÒÁõ°­ºñ
  • oxygen enhancement ratio =OER
    »ê¼ÒÈ¿°úÁõ°­·ü(¡­üùÍýñòË­ëÒ).
  • phase ratio
    »óºñ(ßÓÝï).
  • primary sex ratio
    ÀÏÂ÷¼º ºñ(ÊÙËÛËÓ).
  • ratio
    ºñ(Ýï)
  • ratio
    ºñ(ËÓ).
  • ratio estimate
    ºñÃßÁ¤·®(ËÓÌ§ËøËâ).
  • ratio intelligence qoutient
    Áö´ÉºñÀ²Áö¼ö
  • ratio of accommodative convergence to accommodation
    Á¶ÀýÆøÁÖºñ
  • ratio of dependants
    ºÎ¾çºñ(ËÓËâËÓ).
  • respiratory exchange ratio
    È£Èí±³È¯ºñÀ²(û¼ýåÎßüµÝïëÒ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 9
MACS maximum aortic cusp separation; myristoylated alanine-rich protein kinase C
MAD major affective disorder; mandibulo-acral dysplasia; maximum allowable dose; methylandrostenediol; m...
MAF macrophage activation factor; macrophage agglutinating factor; maximum atrial fragmentation; minimum...
MAS magic angle spinning; Manifest Anxiety Scale; maximum average score; McCune-Albright syndrome; mecon...
max maxilla, maxillary; maximum
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 9
MUCP Maximum urethral closure pressure
MVO Maximum venous outflow
1 RM One-repetition maximum
REML Restricted Maximum Likelihood
"Tm" Transport maximum
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • tissue displaceability
    Á¶Á÷ÀÇ °¡µ¿¼º, Á¶Á÷ º¯À§¼º
    Á¶Á÷ÀÌ ¿ÏÀüÈ÷ ÀÌ¿ÏµÈ »óŸ¦ Á¦¿ÜÇÑ ±¸°­³» Á¶Á÷ÀÇ °¡µ¿Àû »óÅÂ.
  • tissue disruption
    Á¶Á÷ ´Ü¿­
  • tissue expander
    Á¶Á÷ È®Àå¼ú
    Á¶Á÷ È®Àå±â´Â 1976³â ½Ç¸®ÄÜÀ¸·Î Á¦Ç°È­µÇ¸é¼­ ³Î¸® »ç¿ëµÇ°í ÀÖ´Ù. Á¶Á÷ È®Àå±âÀÇ ÀÀ¿ëÀº µÎÇÇ Àç°Ç, ¾È¸éºÎ ¹× °æºÎ
  • tissue fluid
    Á¶Á÷ ¾×
    Ç÷¾×ÀÌ µ¿¸Æ¼º ¸ð¼¼Ç÷°üÀ» Åë°úÇÒ ¶§ ÀϺΠÇ÷Àå ¼ººÐÀÌ ´Ü¼øÇÑ È®»ê¿¡ ÀÇÇÏ¿© ¾ãÀº ³»ÇÇ º®À» ¶Õ°í °áÇÕÁ¶Á÷ ¾ÈÀ¸·Î ³ª¿Â °ÍÀ¸·Î, ¾çÀº Á¶Á÷¿¡ µû¶ó, ¶Ç´Â Á¶Á÷ÀÇ »ý¸® ¹× º´Àû »óÅ¿¡ µû¶ó¼­µµ ¼­·Î ´Ù¸£´Ù.
  • tissue fragmentation velocity
    Á¶Á÷ ºÐ¼â ¼Óµµ
  • tissue integration
    Á¶Á÷ À¶ÇÕ
    ¼­·Î ´Ù¸¥ Á¶Á÷°£¿¡ ¼­·Î À¶ÇÕÇÏ´Â °Í.
  • tissue mass
    Á¶Á÷ µ¢¾î¸®
  • tissue necrosis
    Á¶Á÷ ±«»ç
    1. »ýü ³»ÀÇ Á¶Á÷ÀÌ ±¹ºÎÀûÀ¸·Î Á×´Â ÀÏ. 2. ±«»çÀÇ Á¾·ù¿¡´Â ÀÀ°í ±«»ç, ¾×È­ ±«»ç, ±«Àú ±«»ç°¡ ÀÖ´Ù.
  • tissue pickup
    Á¶Á÷ Áý°Ô, Á¶Á÷ äÃë
  • tissue registration
    Á¶Á÷ ±â·Ï
    ÀλóÀ» ¶æÇÑ´Ù. Áï, ÀûÇÕÇÑ Àç·áÀ» »ç¿ëÇÏ¿© ÀÏÁ¤ÇÑ »óÅÂÀÇ Á¶Á÷ ÇüŸ¦ ÀαâÇØ ³»´Â °ÍÀÌ´Ù.
  • tissue space
    Á¶Á÷ °£°Ý
    Á¶Á÷µé°£ÀÇ °Å¸®, °£°Ý.
  • tissue tag
    Á¶Á÷ ÀÜ»ç
  • tissue trimming
    Á¶Á÷ ¼ÕÁú
  • tissue valve
    Á¶Á÷ ÆÇ¸·
    µ¿ÀǾî=bio
  • tissue-borne partial denture
    Á¶Á÷ ÀÇÄ¡
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
hyaline degeneration of the elastic tissue of the arterial wall Seen during involution of the uterus.
(05 Mar 2000)
skeletal muscle tissue <anatomy, pathology> A rather non-specific term usually applied to the striated muscle of vertebrates that is under voluntary control.
The muscle fibres are syncytial and contain myofibrils, tandem arrays of sarcomeres.
(18 Nov 1997)
skin and connective tissue diseases A collective term for diseases of the skin and its appendages and of connective tissue.
(12 Dec 1998)
smooth muscle tissue <anatomy, pathology, physiology> Muscle tissue in vertebrates made up from long tapering cells that may be anything from 20-500m long.
Smooth muscle is generally involuntary and differs from striated muscle in the much higher actin/myosin ratio, the absence of conspicuous sarcomeres and the ability to contract to a much smaller fraction of its resting length. Smooth muscle cells are found particularly in blood vessel walls, surrounding the intestine (particularly the gizzard in birds) and in the uterus.
The contractile system and its control resemble those of motile tissue cells (e.g. Fibroblasts, leucocytes) and antibodies against smooth muscle myosin will cross react with myosin from tissue cells, whereas antibodies against skeletal muscle myosin will not.
See: dense bodies.
(18 Nov 1997)
soft tissue infections Infections of non-skeletal tissue, i.e., exclusive of bone, ligaments, cartilage, and fibrous tissue. The concept is usually referred to as skin and soft tissue infections and usually subcutaneous and muscle tissue are involved. The predisposing factors in anaerobic infections are trauma, ischemia, and surgery. The organisms often derive from the faecal or oral flora, particularly in wounds associated with intestinal surgery, decubitus ulcer, and human bites.
(12 Dec 1998)
soft tissue injuries Injuries of tissue other than bone. The concept is usually general and does not customarily refer to internal organs or viscera. It is meaningful with reference to regions or organs where soft tissue (muscle, fat, skin) should be differentiated from bones or bone tissue, as "soft tissue injuries of the hand".
(12 Dec 1998)
soft tissue neoplasms Neoplasms of whatever cell type or origin, occurring in the extraskeletal connective tissue framework of the body including the organs of locomotion and their various component structures, such as nerves, blood vessels, lymphatics, etc.
(12 Dec 1998)
soft tissue sarcoma A sarcoma that begins in the muscle, fat, fibrous tissue, blood vessels, or other supporting tissue of the body. Not a type of bone cancer.
(12 Dec 1998)
soft tissue window mediastinal window
nasion soft tissue The outer point of intersection between the nasion-sella line and the soft tissue profile.
(05 Mar 2000)
neoplasms, adipose tissue Neoplasms composed of fatty tissue or connective tissue made up of fat cells in a meshwork of areolar tissue. The concept does not refer to neoplasms located in adipose tissue.
(12 Dec 1998)
neoplasms, bone tissue Neoplasms composed of bony tissue, whether normal or of a soft tissue which has become ossified. The concept does not refer to neoplasms located in bones.
(12 Dec 1998)
neoplasms, connective and soft tissue Neoplasms developing from some structure of the connective and subcutaneous tissue. The concept does not refer to neoplasms located in connective or soft tissue.
(12 Dec 1998)
neoplasms, connective tissue Neoplasms composed of connective tissue, including elastic, mucous, reticular, osseous, and cartilaginous tissue. The concept does not refer to neoplasms located in connective tissue.
(12 Dec 1998)
neoplasms, fibrous tissue Neoplasms composed of fibrous tissue, the ordinary connective tissue of the body, made up largely of yellow or white fibres. The concept does not refer to neoplasms located in fibrous tissue.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 9
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 9
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 9
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 9
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 9
ÅëÇÕ°Ë»ö ¿Ï·á